<DOC>
	<DOCNO>NCT01281111</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , PK different dos dose regimen BG00012 administer without ASA compare placebo .</brief_summary>
	<brief_title>Alternate Dosing Regimens BG00012 Healthy Volunteers</brief_title>
	<detailed_description>Preclinical safety margin BG00012 allow maximum daily dose 720 mg daily . The study use variety clinical scale , include flush scale derive validated questionnaire [ Norquist 2007 ] , good understand safety tolerability several dos dose regimen BG00012 total daily dose 720 mg . The etiology BG00012-induced flushing assess collect relevant biomarker data impact ASA flushing evaluate . Assessments relate GI symptom also perform .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Dimethyl Fumarate</mesh_term>
	<criteria>Ability understand purpose risk study provide sign date informed consent authorization use protect health information ( PHI ) accordance national local subject privacy regulation . Aged 18 55 year old , inclusive , time informed consent . Must good health , determine Investigator , base medical history screening evaluation . Must body mass index 18 34 kg/m2 , inclusive . Subjects childbearing potential must practice effective contraception study willing able continue contraception 30 day last dose study treatment . History clinically significant cardiac , endocrinologic , GI , hematologic , hepatic , immunologic , metabolic , urologic , pulmonary , neurologic , dermatologic , psychiatric , renal , major disease , determine Investigator . History malignant disease , include solid tumor hematologic malignancy ( except basal cell squamous cell carcinoma skin completely excise consider cure ) . Serious infection ( e.g. , pneumonia , septicemia ) determine Investigator within 3 month prior Day 1 . Diarrhea , constipation , abdominal pain , flushing , nausea within 28 day prior Day 1 . History severe allergic anaphylactic reaction . Additionally , subject history intolerance ASA nonsteroidal antiinflammatory drug ( NSAIDS ) must exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>